Brief: Cabaletta Bio Reports First Quarter 2022 Financial Results And Provides Business Update
12/05/2022 12:02
May 12 (Reuters) - Cabaletta Bio Inc CABA.O :
* CABALETTA BIO REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES BUSINESS UPDATE
* CABALETTA BIO - EXPECTS ITS CASH, CASH EQUIVALENTS &
INVESTMENTS
AS OF MARCH 31, 2022 WILL ENABLE IT TO FUND ITS OPERATING PLAN
THROUGH Q3 OF 2023
* QTRLY LOSS PER SHARE $0.45
* Q1 EARNINGS PER SHARE VIEW $-0.60 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX7fjJgM
Further company coverage: CABA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cabaletta Bio
See all newsCabaletta Bio Q1 net loss widens as R&D costs rise
Brief: First Patients Dosed With Cabaletta Bio’S Rese-Cel Manufactured On Cellares' Automated Cell Shuttle™ Platform
Brief: IND Amendment Clearance Obtained For Clinical Manufacturing Of Rese-Cel From Cabaletta Bio Using Cellares' Automated Platforms
Cabaletta Bio reports smaller-than-expected Q3 loss
U.S. RESEARCH ROUNDUP-Beacon Financial, Comerica, Doximity